Can clean energy and technology address environmental sustainability in G7 under the pre-set of human development?

Climate change presents challenges for both industrialized and developing nations, primarily due to insufficient pollution control. Increased fossil fuel usage escalates pollution levels, emphasizing the need to integrate more renewable energy into the energy mix, particularly to reduce carbon emissions. Consequently, public investment in renewable energy becomes pivotal to enhance the necessary technology for green energy production. Human development and technological progress play a crucial role in advancing green energy and ensuring environmental sustainability. This study addresses whether clean energy and technology can foster ecological sustainability in the G7 while considering human development. Findings emphasize the significance of public investments in renewable energy projects, technical innovation, and human development. Such investments are essential for augmenting renewable energy shares and lowering carbon emissions in the long run. The study proposes relevant policies to help G7 nations achieve United Nations Sustainable Development Goals related to green energy transition (SDG-7), environmental sustainability (SDG-13), and innovation (SDG-9). In essence, prioritizing renewable energy investment and innovation is imperative for sustainable development.

Rubella virus IgM and IgG antibodies with avidity in pregnant women and outcomes at a tertiary facility in Ghana.

BACKGROUND: Congenital rubella syndrome (CRS) is a recognised cause of childhood deafness and blindness caused by the transplacental transmission of rubella virus during pregnancy. Women in the reproductive age group, and by extension their unborn babies may therefore be at increased risk. The prevalence of Rubella virus specific IgM and IgG antibodies, including IgG avidity, was determined in pregnant women attending the antenatal clinic at a Teaching Hospital in Ghana. METHODS: One hundred and forty-five women in their second and third trimesters of pregnancy from the outpatient clinic were recruited over a period of 2 months after written informed consent was obtained. Study participants completed a questionnaire and venous blood drawn for IgM, IgG, and avidity testing using SERION ELISA (SERION® Immunologics, Würzburg, Germany). Babies of mothers with positive or indeterminate IgM and low avidity IgG antibodies were offered specialist cardiological, ophthalmological or hearing assessment during follow up. RESULTS: One hundred and twenty-eight (88.3%) had only IgG antibodies, 5 (3.4%) had IgM and IgG antibodies, while 12 (8.3%) had no antibodies. No patient had IgM antibodies alone. Ten women (6.9%) had indeterminate levels of IgM antibodies. Majority of the women had high avidity IgG antibodies, while 5 (3.4%) had low avidity antibodies. No patient had IgM with low avidity antibodies. There was no statistical association between socio-demographic factors and the presence of IgM, IgG (low or high avidity) antibodies. Of all the children followed, none had the clinical definition of CRS. CONCLUSIONS: Consistent with the World Health Organization elimination strategy for measles and rubella viruses, non-immune women in the reproductive age group should be vaccinated. The immunization programme should be expanded to include teenagers and adults. Though Congenital Rubella Syndrome was not detected, the risk still remains.